Axoguard HA+ for Head and Neck Cancers

ME
Overseen ByMatthew E Spector, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Matthew Spector
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a treatment called Axoguard HA+ Nerve Protector for individuals with head and neck cancers undergoing surgery. The main goal is to determine if wrapping a nerve in the shoulder with this treatment during surgery improves shoulder function after one year. Individuals who have not received previous treatments for their head or neck cancer and are undergoing specific types of neck surgery may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to medical research and potentially enhance future treatment options.

What prior data suggests that the Axoguard HA+ Nerve Protector is safe for patients with head and neck cancers?

Research has shown that the Axoguard HA+ Nerve Protector is usually well-tolerated in surgeries. Studies have found it helps protect nerves and aids in healing. However, some people report side effects like nausea and pain. These side effects are common in medical treatments and can usually be managed. Discuss any concerns with your doctor to determine if this trial might be suitable for you.12345

Why are researchers excited about this trial?

Axoguard HA Plus Nerve Protector is unique because it focuses on protecting and repairing nerves affected by head and neck cancers, which is not the primary focus of traditional treatments like surgery, radiation, and chemotherapy. Unlike these standard treatments that aim to remove or destroy cancer cells, Axoguard HA Plus uses a specialized nerve protector that may help preserve nerve function and improve recovery outcomes. Researchers are excited about this treatment because it offers a novel approach that could potentially enhance quality of life for patients by reducing side effects associated with nerve damage.

What evidence suggests that the Axoguard HA+ Nerve Protector is effective for improving shoulder function in head and neck cancer patients?

Research shows that the Axoguard HA+ Nerve Protector can improve nerve healing and reduce post-surgery complications. In previous studies, surgeons wrapped it around nerves to prevent scar tissue, allowing smoother nerve movement. This may result in less pain and improved mobility. Early results suggest that patients experienced fewer shoulder issues after using Axoguard HA+ during surgery. In this trial, participants will receive the Axoguard HA+ treatment, designed to protect nerves and potentially improve outcomes for those undergoing neck surgery.12346

Who Is on the Research Team?

DZ

Daniel Zandberg

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for patients with head and neck cancers who are scheduled to undergo neck dissection surgery. The study aims to include those who can be assessed for shoulder function about a year after their operation.

Inclusion Criteria

I am having a specific neck surgery that preserves certain nerves.
Patients must give documented informed consent to participate in this study
I am 18 years old or older.
See 1 more

Exclusion Criteria

I cannot have surgery because it's unsafe for me to be put under general anesthesia.
I have had neck or shoulder surgery or radiation in the past.
Known sensitivity to porcine materials
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery

Patients undergo neck dissection and the spinal accessory nerve is wrapped with the Axoguard HA+ Nerve Protector

1 day
1 visit (in-person)

Post-operative Assessment

The presence and severity of neck and shoulder dysfunction are assessed approximately twelve months post-operatively

12 months
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Axoguard HA Plus Nerve Protector

Trial Overview

The intervention being tested is the use of Axoguard HA+ Nerve Protector during surgery, which involves wrapping the nerve that goes to the shoulder in hopes of improving post-operative shoulder function.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Axoguard HA+ ArmExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Matthew Spector

Lead Sponsor

Trials
1
Recruited
230+

Axogen Corporation

Industry Sponsor

Trials
11
Recruited
5,600+

Citations

Axoguard HA Plus Nerve Protector to Reduce Post ...

In this prospective study, patients with head and neck cancers undergoing neck dissection will have the nerve to the shoulder wrapped with the ...

Axoguard HA+ Nerve Protector

Learn about Axoguard HA+ Nerve Protector® and see how surgeons are using it for enhanced nerve gliding and minimizariun of soft tissue attachments.

Case Overview: Axoguard HA+ Nerve Protector®

Matthew Wilson, MD, shares his experience with Axoguard HA+ Nerve Protector®. A patient presented with significant pain and paresthesia ...

axgn-20231231 - Investor Relations - axogen

We have applied the average sales price of the Avance Nerve Graft, Axoguard Nerve Connector, and Axoguard Nerve Protector that address such PNI ...

MAUDE Adverse Event Report: AXOGEN CORPORATION ...

MAUDE Adverse Event Report: AXOGEN CORPORATION AXOGUARD HA+ NERVE PROTECTOR; NERVE CUFF ; Patient Problems Nausea (1970); Pain (1994) ; Event Date ...

MAUDE Adverse Event Report: AXOGEN CORPORATION ...

The issue arose after the removal of the skin stitches, leading to the dehiscence of the proximal incision, which ultimately required the axoguard ha+ nerve ...